The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Intra-arterial gemcitabine versus intravenous gemcitabine: Pharmacokinetic and pharmacodynamic sub-study of the TIGeR-PaC phase 3 clinical trial.
 
Paula Novelli
No Relationships to Disclose
 
Amer Zureikat
No Relationships to Disclose
 
Michael Pishvaian
Stock and Other Ownership Interests - Perthera; Tumor Board Tuesday
Consulting or Advisory Role - Astellas Pharma; Merck; Merus; Moderna Therapeutics; Pfizer; Renovo Rx; Revolution Medicines; Seagen; Serna Bio; Theriva Biologics
Research Funding - Actuate Therapeutics (Inst); Amgen (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); BioMed Valley Discoveries (Inst); Boehringer Ingelheim (Inst); Elevation Oncology (Inst); Hutchison MediPharma (Inst); IDEAYA Biosciences (Inst); Lilly (Inst); Lilly (Inst); MEI Pharma (Inst); Merck (Inst); Novartis (Inst); Parabalis (Inst); Pfizer (Inst); Recursion Pharmaceuticals (Inst); Repare Therapeutics (Inst); Seagen (Inst); Takeda (Inst); Tesaro (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Perthera patient matching algorithm
Travel, Accommodations, Expenses - Astellas Pharma; Merus; RenovoRx; Revolution Medicines
 
Kenneth Meredith
No Relationships to Disclose
 
Hassan Hatoum
Consulting or Advisory Role - AstraZeneca; Exelixis
Research Funding - Natera (I)
 
Emmanuel Zervos
No Relationships to Disclose
 
Reza Nazemzadeh
Stock and Other Ownership Interests - Abbvie; Akero Therapeutics; Alector; Amgen; ESSA; Exelixis; Johnson & Johnson; Kura Oncology; MacroGenics; Pfizer
 
Sandeep Laroia
No Relationships to Disclose
 
Pashtoon Kasi
Leadership - Precision Biosensors
Stock and Other Ownership Interests - Elicio Therapeutics
Consulting or Advisory Role - Agenus; Astellas Pharma; Bayer; BeiGene; BostonGene; BostonGene; Daiichi Sankyo/Astra Zeneca; Delcath Systems; Eisai; Elicio Therapeutics; Exact Sciences; Foundation Medicine; Guardant Health; Illumina; Ipsen (Inst); Lilly; MSD Oncology; Natera; NeoGenomics Laboratories; QED Therapeutics; Regeneron; SAGA Diagnostics; Seagen; SERVIER; Taiho Oncology; Taiho Pharmaceutical (Inst); Tempus; Xilio Therapeutics
Research Funding - Advanced Accelerator Applications (Inst); Agenus (Inst); Boston Scientific (Inst); Merck (Inst); Tersera (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Ramtin Agah
Employment - RenovoRx
Leadership - RenovoRx
Stock and Other Ownership Interests - RenovoRx
Research Funding - RenovoRx
Patents, Royalties, Other Intellectual Property - RenovoRx